Dr. Anu Antony is the Chief Medical Officer of SimBioSys, a technology company that predicts tumor responses to therapy. Dr. Antony has dedicated the last 15 years of her career to the service of breast cancer patients as a board-certified surgeon specializing in oncologic reconstructive surgery. She completed her residency at Stanford University Medical Center in general surgery and plastic surgery; holds a Master of Public Health in Biostatistics from the Harvard School of Public Health and an Executive MBA from the Northwestern Kellogg School of Management. Dr. Antony has held several prestigious positions in the Chicagoland area, including Professor and Vice-Chair of the Department of Surgery and Chief of Breast Reconstruction at Rush University Medical Center in Chicago, Vice-Chair of the University of Illinois Breast Cancer Center, and President of her regional and state professional societies.
There is a need for sophisticated and accurate forecasting software tools that incorporate precision cancer care. Technology and artificial intelligence, in particular, have the potential to improve clinical decision-making.